ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) Total liabilities 2020–2025
ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) total liabilities at each fiscal year-end, per SEC filings.
$243.5MFY2025 · since FY2020: $27.6M → $243.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $243.5M | +27.3% |
| FY2024 | $191.3M | -24.3% |
| FY2023 | $252.7M | +5.4% |
| FY2022 | $239.7M | +117.0% |
| FY2021 | $110.5M | +299.6% |
| FY2020 | $27.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More ARQT financial trends
ARQT RevenueARQT Net incomeARQT Net marginARQT Gross profitARQT Gross marginARQT Operating incomeARQT Operating marginARQT Operating cash flowARQT Free cash flowARQT Capital expendituresARQT Return on equityARQT Stock buybacksARQT Dividends paidARQT Total assetsARQT Shareholders’ equityARQT overview →